NCT04869774

Brief Summary

The purpose of this study is to assess the feasibility of using a mobile application (app) called how2trak to improve people's experience, wound surveillance, and detection of surgical site infections (SSI) after colorectal surgery while reducing in-person interactions for patients during the COVID-19 pandemic. This will inform the implementation of a full-scale trial to establish if surveillance of someone's incision and symptoms using how2trak improves SSI detection and management compared to standard care (involving a single post-operative surgery clinic visit). The data collected will contribute to a broader dataset of people with SSI surveillance to be used in developing a clinical decision support system.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2021

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 23, 2021

Completed
8 days until next milestone

Study Start

First participant enrolled

May 1, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 3, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2022

Completed
Last Updated

May 3, 2021

Status Verified

April 1, 2021

Enrollment Period

6 months

First QC Date

April 23, 2021

Last Update Submit

April 28, 2021

Conditions

Outcome Measures

Primary Outcomes (7)

  • Capability for enrollment

    number of patients per month on average are enrolled in the study

    6 months

  • Feasibility of the randomization processes

    proportion of patients randomized to the intervention or control group.

    6 months

  • How2trak compliance

    Proportion of self-assessments completed by patients, on average.

    6 months

  • How2trak usability, delivery and compliance

    The mean score for the patient and clinician survey of H2T application.

    6 months

  • Monitoring of protocol deviation and safety

    The number and frequency of events when study activities diverge from the REB-approved protocol or are considered adverse events.

    6 months

  • Feasibility of data extraction

    Proportion of patients for which all primary outcomes of the definitive trial are recorded. This includes the SSI incidence and severity and patient experience.

    6 months

  • Resources and time required to conduct the feasibility trial will be assessed

    There is adequate administrative capacity, expertise, skills, space and time of the research team to complete the study.

    8 months

Secondary Outcomes (4)

  • Surgical Site Infection (SSI) Rate

    6 months

  • Patient experience

    6 months

  • Healthcare System Time

    6 months

  • Covid-19 infection Rate

    6 months

Study Arms (2)

Virtual Monitoring

ACTIVE COMPARATOR

Patients discharged from hospital after colorectal surgery will have virtual monitoring of their surgical incision and symptoms, using the mobile application How2Trak, post-operatively.

Device: How2Trak mobile application

Standard of Care

NO INTERVENTION

Patients discharged from hospital after colorectal surgery will receive standard of care with no virtual monitoring of their surgical incision and symptoms.

Interventions

Patients will undergo virtual monitoring of their incision and symptoms using the How2Trak application(app). Using the app, patients will be asked to answer a series of questions and photograph their surgical incision on post-operative day 3, 5, 7, 10, 20, and 30. Patient responses and photographs entered into the app will be reviewed within 72 hours by a trained Nurse Specialized in Wound, Ostomy and Continence. If a concern is identified the nurse will contact the patient to arrange a virtual visit using the how2trak app or notify the surgeon team (including colorectal surgeons and physician residents) in accordance with clinical discretion.

Virtual Monitoring

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients must be 16 years of age or older who are being discharged from hospital after undergoing semi-urgent, urgent, or elective abdominal surgery by a colorectal surgeon at The Ottawa Hospital, and have provided informed consent to participate.
  • Patients enrolled in other clinical trials will still be candidates for this feasibility trial.
  • Clinicians using the how2trak app in this study will be considered study participants as well. They will be asked to complete the "Patient and Clinician Survey of Application". This survey addresses the experience with the use of the H2T app their feedback regarding usability is fundamental for future improvement.

You may not qualify if:

  • Individuals will be excluded if less than 16 years of age; have no access or ability to use a mobile device; no cellular data/WiFi access; and/or cannot read and write in English.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Valk HA, Garcia-Ochoa C, Fontaine Calder J, Miller T, Rashidi B, McIsaac C, Musselman R. A Mobile App for Wound and Symptom Surveillance After Colorectal Surgery: Protocol for a Feasibility Randomized Controlled Trial. JMIR Res Protoc. 2022 Jan 14;11(1):e26717. doi: 10.2196/26717.

MeSH Terms

Conditions

Surgical Wound Infection

Condition Hierarchy (Ancestors)

Wound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Reilly Musselman, MD, MSc

    University of Ottawa

    PRINCIPAL INVESTIGATOR
  • Heather Smith, MD, MSc

    University of Ottawa

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Reilly Musselman, MD, MSc

CONTACT

Heather Smith, MD,MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
This study will be unblinded so no attempts at concealment of individuals' allocation will be made.
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 23, 2021

First Posted

May 3, 2021

Study Start

May 1, 2021

Primary Completion

November 1, 2021

Study Completion

February 1, 2022

Last Updated

May 3, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

There are no plans to share IPD with other partners, collaborators, or researchers. Data will be captured through the assessments and/or photographs in the app and EPIC. Data sent from how2trak to TOH will be transferred through a secure, access-controlled folder within Office 365 including patient identifiers to allow for merging with EPIC data. Once the data files are merged, they will be deidentified. Only research personnel will have access to the study data. A data monitoring committee will not be developed given the minimal risk and small sample size of this feasibility trial.